Fortress Biotech
FBIO
48 hedge funds and large institutions have $7.2M invested in Fortress Biotech in 2023 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 10 increasing their positions, 13 reducing their positions, and 8 closing their positions.
3,400% more call options, than puts
Call options by funds: $35K | Put options by funds: $1K
0% more funds holding
Funds holding: 48 → 48 (0)
0% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 8
0.07% less ownership
Funds ownership: 1.2% → 1.13% (-0.07%)
23% less repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 13
46% less capital invested
Capital invested by funds: $13.3M → $7.2M (-$6.08M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wealth Enhancement Advisory Services
Plymouth,
Minnesota
|
+$705K |
| 2 |
Renaissance Technologies
New York
|
+$43.5K |
| 3 |
Wells Fargo
San Francisco,
California
|
+$35.8K |
| 4 |
BWM
Bulltick Wealth Management
Miami,
Florida
|
+$32K |
| 5 |
Jane Street
New York
|
+$27.4K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
OM
Opaleye Management
Boston,
Massachusetts
|
-$599K |
| 2 |
Corient Private Wealth
Miami,
Florida
|
-$455K |
| 3 |
1WM
1900 Wealth Management
San Antonio,
Texas
|
-$224K |
| 4 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
-$170K |
| 5 |
Morgan Stanley
New York
|
-$47.9K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
51
Charles Schwab
San Francisco,
California
| – | -$16.5K | -1,998 | Closed |
|
52
Citadel Advisors
Miami,
Florida
| – | -$7.75K | -1,129 | Closed |
|
53
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$6.21K | -905 | Closed |
|
54
Victory Capital Management
San Antonio,
Texas
| – | -$5.58K | -677 | Closed |
|
55
Barclays
London,
United Kingdom
| – | -$136 | -16 | Closed |
|
56
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | +$96 | +14 | +45% |
|
FBIO Hedge Fund Activity: Q3 2023 in Review
48 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in Fortress Biotech (FBIO) for Q3 2023, worth a combined $7.2M — down 46% from $13.3M a quarter earlier.
Fund positioning in FBIO was balanced in Q3 2023: 8 funds opened new positions, 8 closed out, 10 added to existing stakes and 13 trimmed.
The largest buyer was Wealth Enhancement Advisory Services, opening a new position worth an estimated $705K. The largest seller was Opaleye Management, cutting an estimated $599K.
- 48 institutional investors held Fortress Biotech (FBIO) as of Q3 2023, unchanged from Q2 2023.
- Funds reported $7.2M of Fortress Biotech stock for Q3 2023, down 46% quarter-over-quarter.
- 8 funds opened new Fortress Biotech positions in Q3 2023 and 8 closed out, a net change of 0 holders.
- The largest Fortress Biotech buyer in Q3 2023 was Wealth Enhancement Advisory Services, an estimated $705K added.
- The largest Fortress Biotech seller in Q3 2023 was Opaleye Management, an estimated $599K sold.
Based on aggregated 13F filings for Q3 2023.